Allarity Therapeutics
Joe Vazzano is an experienced finance professional with a strong background in leadership roles within the pharmaceutical industry. Currently serving as a Board Member and Audit Chair at Allarity Therapeutics, Joe has previously held the position of Chief Financial Officer at both Abeona Therapeutics and Avenue Therapeutics, where Joe also contributed as Vice President of Finance and Corporate Controller. Additionally, Joe held the role of Assistant Corporate Controller at Intercept Pharmaceuticals and served as Assistant Controller at Pernix Therapeutics. Joe Vazzano earned a Bachelor of Science degree in Accounting from Lehigh University College of Business between 2002 and 2006.
This person is not in any offices
Allarity Therapeutics
2 followers
Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.